Modified virus tested as new weapon against tough cancers
NCT ID NCT07262164
Summary
This is an early-stage study to test the safety of a new cancer treatment called VG2062. The treatment uses a modified herpes virus designed to target and kill cancer cells. The study will enroll about 30 adults with advanced solid tumors that have stopped responding to standard therapies to find the safest and most effective dose.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED MALIGNANT SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
No. 67, Huayuan Road, Langfang Economic and Technological Development Zone, Hebei Province
RECRUITINGHebei, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.